Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,890 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The International Diabetes Federation's guide for diabetes epidemiological studies.
Aschner P, Karuranga S, James S, Simmons D, Basit A, Shaw JE, Wild SH, Ogurtsova K, Saeedi P; International Diabetes Federation's Diabetes Epidemiological Guide Writing Group. Aschner P, et al. Among authors: simmons d. Diabetes Res Clin Pract. 2021 Feb;172:108630. doi: 10.1016/j.diabres.2020.108630. Epub 2020 Dec 23. Diabetes Res Clin Pract. 2021. PMID: 33347900 No abstract available.
Prevalence of diabetes in rural Victoria.
Simmons D, McKenzie A, Eaton S, Shaw J, Zimmet P. Simmons D, et al. Diabetes Res Clin Pract. 2005 Dec;70(3):287-90. doi: 10.1016/j.diabres.2005.04.004. Epub 2005 Jun 8. Diabetes Res Clin Pract. 2005. PMID: 15946759
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?
Harding J, Sooriyakumaran M, Anstey KJ, Adams R, Balkau B, Briffa T, Davis TM, Davis WA, Dobson A, Giles GG, Grant J, Knuiman M, Luszcz M, Mitchell P, Pasco JA, Reid C, Simmons D, Simons L, Tonkin A, Woodward M, Shaw JE, Magliano DJ. Harding J, et al. Among authors: simmons d. Diabetes Metab. 2015 Dec;41(6):463-9. doi: 10.1016/j.diabet.2015.04.006. Epub 2015 May 30. Diabetes Metab. 2015. PMID: 26037090
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations.
Reutens AT, Jandeleit-Dahm K, Thomas M, Salim A, De Livera AM, Bach LA, Colman PG, Davis TME, Ekinci EI, Fulcher G, Hamblin PS, Kotowicz MA, MacIsaac RJ, Morbey C, Simmons D, Soldatos G, Wittert G, Wu T, Cooper ME, Shaw JE. Reutens AT, et al. Among authors: simmons d. Contemp Clin Trials. 2020 Mar;90:105892. doi: 10.1016/j.cct.2019.105892. Epub 2019 Nov 16. Contemp Clin Trials. 2020. PMID: 31740428 Clinical Trial.
1,890 results